ArticleOphthalmology science
Deep Learning-Driven Exophthalmometry through Facial Photographs in Thyroid Eye Disease.
Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Marker-Free, Automated Eyelid Assessment in Thyroid Eye Disease Using Artificial Intelligence: A Multicenter Validation Study.Ophthalmology science · 2026Article
- ProptoView: AI-based digital exophthalmometry using multi-view facial images in a multinational validation study.Journal of translational medicine · 2026Article
- What has changed in thyroid eye disease in the last five years (2020-2025).European thyroid journal · 2026Review
- The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI.Frontiers in medicine · 2026Review
- AI-based assessment of Clinical Activity Score and detection of active thyroid eye disease using facial images: validation of Glandy CAS.BMJ open ophthalmology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and evaluate a deep learning (DL)-assisted system for proptosis measurement using facial photographs in thyroid eye disease (TED). Design: A retrospective cohort study. Participants: This study included 1108 patients with TED from Severance Hospital (SH) and 171 from Seoul National University Bundang Hospital (SNUBH). Methods: The DL-assisted system was trained using 1610 facial images paired with Hertel exophthalmometry measurements from SH and externally validated using 511 SNUBH images. The system employs a dual-stream ResNet-18 neural network, utilizing both red-green-blue images and depth maps generated by the ZoeDepth algorithm. Main Outcome Measures: Accuracy was assessed using mean absolute error (MAE), Pearson correlation coefficient, intraclass correlation coefficient (ICC), and area under the curve of the receiver operating characteristic curve. Results: The DL-assisted system achieved an MAE of 1.27 mm for the SH dataset and 1.24 mm for the SNUBH dataset. Pearson correlation coefficients were 0.82 and 0.77, respectively, with ICCs indicating strong reliability (0.80 for SH and 0.73 for SNUBH). The receiver operating characteristic curve analysis showed area under the curves of 0.91 for SH and 0.88 for SNUBH in detecting proptosis. The system detected significant proptosis changes (≥ 2 mm) with 74.6% accuracy. Conclusions: The DL-assisted system offers an accurate, accessible method for exophthalmometry in patients with TED using facial photographs. This tool presents a promising alternative to traditional exophthalmometry, potentially improving access to reliable proptosis measurement in both clinical and nonspecialist settings. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.